Summary With the release of Version 24, the Simcyp Simulator introduces cutting-edge enhancements that further elevate its capabilities. The latest features in Version 24 include: Enhanced user experience with modernized...
Abstract This study conducted a population pharmacokinetic (PK) and pharmacodynamic (PD) analysis of navtemadlin, an MDM2 inhibitor, across multiple cancer types, including relapsed and refractory (R/R) myelofibrosis (MF), Merkel cell...
You May Also Like AllVideo Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at CertaraBlending Science & Impact in Drug Development: Felix Boakye-Agyeman,...
Events & WebinarsCertara’s Events for Scientists, Industry Leaders and Investors Stay up to date with the latest conferences and webinars Sign up Featured conference 2025 SNMMI Annual Meeting June 21...
Videos Keep up to date with the latest resources Sign up Featured video AllVideo Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at...
Press Releases Keep up to date with the latest resources Sign up Featured press release AllPress Release Certara Reports First Quarter 2025 Financial ResultsCertara Reports First Quarter 2025 Financial ResultsCertara...
Posters Keep up to date with the latest resources Sign up Featured poster AllPoster A minimal physiologically-based pharmacokinetic/pharmacodynamic mouse xenograft model to inform the evaluation of 212Pb-based Radio-DARPins targeting DLL3A...